
Joseph H. Murray
Examiner (ID: 1129)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1613, 1626 |
| Total Applications | 346 |
| Issued Applications | 321 |
| Pending Applications | 11 |
| Abandoned Applications | 14 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5224740
[patent_doc_number] => 20070254006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Medical Devices and Coatings with Non-Leaching Antimicrobial Peptides'
[patent_app_type] => utility
[patent_app_number] => 11/675500
[patent_app_country] => US
[patent_app_date] => 2007-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14941
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254006.pdf
[firstpage_image] =>[orig_patent_app_number] => 11675500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/675500 | Medical Devices and Coatings with Non-Leaching Antimicrobial Peptides | Feb 14, 2007 | Abandoned |
Array
(
[id] => 4989313
[patent_doc_number] => 20070155654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Novel formulations'
[patent_app_type] => utility
[patent_app_number] => 11/701083
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3277
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155654.pdf
[firstpage_image] =>[orig_patent_app_number] => 11701083
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/701083 | Novel formulations | Jan 31, 2007 | Abandoned |
Array
(
[id] => 5086077
[patent_doc_number] => 20070276128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Stabilized Proteins with Engineered Disulfide Bonds'
[patent_app_type] => utility
[patent_app_number] => 11/627197
[patent_app_country] => US
[patent_app_date] => 2007-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 17405
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20070276128.pdf
[firstpage_image] =>[orig_patent_app_number] => 11627197
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/627197 | Stabilized proteins with engineered disulfide bonds | Jan 24, 2007 | Issued |
Array
(
[id] => 6070198
[patent_doc_number] => 20110045048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'BONE GRAFT AND SCAFFOLDING MATERIALS IMMOBILIZED WITH TYPE I COLLAGEN BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/278009
[patent_app_country] => US
[patent_app_date] => 2007-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4176
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045048.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278009
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278009 | Bone graft and scaffolding materials immobilized with type I collagen binding peptides | Jan 18, 2007 | Issued |
Array
(
[id] => 4669300
[patent_doc_number] => 20080044360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'METHODS OF COLLAGEN IMAGING'
[patent_app_type] => utility
[patent_app_number] => 11/618458
[patent_app_country] => US
[patent_app_date] => 2006-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 54302
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044360.pdf
[firstpage_image] =>[orig_patent_app_number] => 11618458
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/618458 | Methods of collagen imaging | Dec 28, 2006 | Issued |
Array
(
[id] => 5231548
[patent_doc_number] => 20070293656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'COLLAGEN BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 11/618564
[patent_app_country] => US
[patent_app_date] => 2006-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 52409
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293656.pdf
[firstpage_image] =>[orig_patent_app_number] => 11618564
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/618564 | COLLAGEN BINDING PEPTIDES | Dec 28, 2006 | Abandoned |
Array
(
[id] => 4772976
[patent_doc_number] => 20080058636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'METHODS OF MYOCARDIAL IMAGING'
[patent_app_type] => utility
[patent_app_number] => 11/618556
[patent_app_country] => US
[patent_app_date] => 2006-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 54873
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058636.pdf
[firstpage_image] =>[orig_patent_app_number] => 11618556
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/618556 | METHODS OF MYOCARDIAL IMAGING | Dec 28, 2006 | Abandoned |
Array
(
[id] => 6377726
[patent_doc_number] => 20100081624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'SELECTIVE PEPTIDES THAT INHIBIT THE BIOLOGICAL ACTIVITY OF CALCINEURIN'
[patent_app_type] => utility
[patent_app_number] => 12/159586
[patent_app_country] => US
[patent_app_date] => 2006-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10919
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081624.pdf
[firstpage_image] =>[orig_patent_app_number] => 12159586
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/159586 | SELECTIVE PEPTIDES THAT INHIBIT THE BIOLOGICAL ACTIVITY OF CALCINEURIN | Dec 26, 2006 | Abandoned |
Array
(
[id] => 5247028
[patent_doc_number] => 20070243262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Stable S-nitrosothiol formulations'
[patent_app_type] => utility
[patent_app_number] => 11/644388
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5569
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243262.pdf
[firstpage_image] =>[orig_patent_app_number] => 11644388
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/644388 | Stable S-nitrosothiol formulations | Dec 20, 2006 | Abandoned |
Array
(
[id] => 8305891
[patent_doc_number] => 08227422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-24
[patent_title] => 'Peptides and compounds that bind to a receptor'
[patent_app_type] => utility
[patent_app_number] => 11/610226
[patent_app_country] => US
[patent_app_date] => 2006-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 23
[patent_no_of_words] => 22527
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11610226
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/610226 | Peptides and compounds that bind to a receptor | Dec 12, 2006 | Issued |
Array
(
[id] => 5514718
[patent_doc_number] => 20090215025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'SMALL PEPTIDIC AND PEPTIDO-MIMETIC AFFINITY LIGANDS FOR FACTOR VIII AND FACTOR VIII-LIKE PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/096503
[patent_app_country] => US
[patent_app_date] => 2006-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15812
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215025.pdf
[firstpage_image] =>[orig_patent_app_number] => 12096503
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/096503 | SMALL PEPTIDIC AND PEPTIDO-MIMETIC AFFINITY LIGANDS FOR FACTOR VIII AND FACTOR VIII-LIKE PROTEINS | Dec 6, 2006 | Abandoned |
Array
(
[id] => 5309676
[patent_doc_number] => 20090016957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'Polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/085576
[patent_app_country] => US
[patent_app_date] => 2006-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 21744
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20090016957.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085576
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085576 | Polypeptides | Dec 4, 2006 | Issued |
Array
(
[id] => 5253889
[patent_doc_number] => 20070135345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Use of GLP-2 for the treatment or prevention, of bone-related disorders'
[patent_app_type] => utility
[patent_app_number] => 11/603793
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27876
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135345.pdf
[firstpage_image] =>[orig_patent_app_number] => 11603793
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/603793 | Use of GLP-2 for the treatment or prevention, of bone-related disorders | Nov 21, 2006 | Abandoned |
Array
(
[id] => 5304129
[patent_doc_number] => 20090298781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'COMPOUNDS FOR THE INHIBITION OF APOPTOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/094828
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9526
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298781.pdf
[firstpage_image] =>[orig_patent_app_number] => 12094828
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/094828 | COMPOUNDS FOR THE INHIBITION OF APOPTOSIS | Nov 21, 2006 | Abandoned |
Array
(
[id] => 5539682
[patent_doc_number] => 20090221487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'POLYETHLENE GLYCOL MODIFICATIONS OF THYMOSIN ALPHA-1'
[patent_app_type] => utility
[patent_app_number] => 12/093240
[patent_app_country] => US
[patent_app_date] => 2006-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5615
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221487.pdf
[firstpage_image] =>[orig_patent_app_number] => 12093240
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/093240 | Polyethlene glycol modifications of thymosin alpha-1 | Nov 10, 2006 | Issued |
Array
(
[id] => 5023799
[patent_doc_number] => 20070149765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Liquid phase peptide syntheses of KL-4 pulmonary surfactant'
[patent_app_type] => utility
[patent_app_number] => 11/581925
[patent_app_country] => US
[patent_app_date] => 2006-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8113
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149765.pdf
[firstpage_image] =>[orig_patent_app_number] => 11581925
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/581925 | Liquid phase peptide syntheses of KL-4 pulmonary surfactant | Oct 16, 2006 | Abandoned |
Array
(
[id] => 4983404
[patent_doc_number] => 20070087963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Synthesis of cyclosporin analogs'
[patent_app_type] => utility
[patent_app_number] => 11/549575
[patent_app_country] => US
[patent_app_date] => 2006-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26942
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20070087963.pdf
[firstpage_image] =>[orig_patent_app_number] => 11549575
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/549575 | Synthesis of cyclosporin analogs | Oct 12, 2006 | Abandoned |
Array
(
[id] => 285507
[patent_doc_number] => 07550434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-23
[patent_title] => 'Stabilized teriparatide solutions'
[patent_app_type] => utility
[patent_app_number] => 11/541862
[patent_app_country] => US
[patent_app_date] => 2006-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2803
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/550/07550434.pdf
[firstpage_image] =>[orig_patent_app_number] => 11541862
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/541862 | Stabilized teriparatide solutions | Oct 1, 2006 | Issued |
Array
(
[id] => 5242849
[patent_doc_number] => 20070021344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Stabilized teriparatide solutions'
[patent_app_type] => utility
[patent_app_number] => 11/541863
[patent_app_country] => US
[patent_app_date] => 2006-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2730
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021344.pdf
[firstpage_image] =>[orig_patent_app_number] => 11541863
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/541863 | Stabilized teriparatide solutions | Oct 1, 2006 | Abandoned |
Array
(
[id] => 5107658
[patent_doc_number] => 20070066536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 11/522038
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10089
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066536.pdf
[firstpage_image] =>[orig_patent_app_number] => 11522038
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/522038 | Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators | Sep 14, 2006 | Abandoned |